N1 (Drug Discovery) Overview
- Year Founded
-
2018
- Status
-
Out of Business
- Latest Deal Type
-
Liquidation
N1 (Drug Discovery) General Information
Description
Developer of a digital healthcare platform designed to assist pharmaceutical companies to create new medicines. The company's platform uses a combination of digital technologies and new research methods, enabling researchers to make the clinical development of new therapies more efficient for smaller patient populations.
Contact Information
Website
www.n1clinical.comCorporate Office
- Rosa-Luxemburg-Straße
- 10178 Berlin
- Germany
Corporate Office
- Rosa-Luxemburg-Straße
- 10178 Berlin
- Germany
N1 (Drug Discovery) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Bankruptcy: Liquidation | 07-Jul-2021 | Completed | Bankruptcy: Liquidation | |||
| 1. Early Stage VC | 12-Oct-2018 | Completed | Generating Revenue |
N1 (Drug Discovery) FAQs
-
When was N1 (Drug Discovery) founded?
N1 (Drug Discovery) was founded in 2018.
-
Where is N1 (Drug Discovery) headquartered?
N1 (Drug Discovery) is headquartered in Berlin, Germany.
-
What industry is N1 (Drug Discovery) in?
N1 (Drug Discovery)’s primary industry is Drug Discovery.
-
Is N1 (Drug Discovery) a private or public company?
N1 (Drug Discovery) is a Private company.
-
What is N1 (Drug Discovery)’s current revenue?
The current revenue for N1 (Drug Discovery) is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process